Impact of Omega-3 Intake During Pregnancy on Maternal Stress and Infant Outcome

怀孕期间 Omega-3 摄入量对母亲压力和婴儿结局的影响

基本信息

  • 批准号:
    7660952
  • 负责人:
  • 金额:
    $ 19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-06 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Pregnant women living in poverty often experience chronic stress, and consequently higher levels of stress hormones. In utero exposure to high levels of stress hormones can negatively affect the developing fetus and later, the infant's capacity for emotion and behavioral regulation. In this proposal we describe a developing program of research designed to reduce the negative impact of prenatal stress on infant health and development via nutritional supplementation of docosahexaenoic acid (DHA) during pregnancy. DHA is a long-chain polyunsaturated fatty acid member of the omega-3 fatty acid family. DHA is found in its highest concentrations in neural cell membranes, affecting receptor function, neurotransmitter uptake, and signal transmission. There is growing evidence that low levels of dietary DHA intake are associated with suboptimal response to stress and that DHA supplementation can modulate stress response. Aims: The goals of the proposed study are to explore whether DHA supplementation during pregnancy is associated with 1) a reduction in maternal perceived stress during pregnancy; 2) a more modulated maternal cortisol response to a stress stimulus during pregnancy, and 3) more optimal regulation of emotion and behavior in the infant. Approach: Sixty-five pregnant women living in inner-city poverty, who consume less than two servings of fish per week, will be randomly assigned to receive 450 mg/daily of DHA or placebo beginning at 16-20 weeks gestation through the end of pregnancy. Perceived stress, pregnancy related stress, stressful life events, anxiety, and depression will be assessed at baseline and at 24, 30, and 36 weeks of pregnancy and at 4 months post-partum. DHA levels will be assessed at baseline and at 36 weeks of pregnancy. Cortisol response to the Trier Social Stress Test will be measured at baseline, 24, and 30 weeks. At 4 months post-partum infant temperament, cognitive development and stress reactivity will be assessed in the laboratory. Investigators: This proposal stems from an NIMH R21 Translational Science Network on prenatal stress and mental health outcomes in the offspring. Three members of that network, Drs. Keenan, Carter, and Glover, are all funded investigators in the area of prenatal stress and child mental health, which is a prioritized area of exploratory research that could directly impact clinical care. They are collaborating on the present application. Innovation: This will be the first randomized controlled study of the effect of DHA supplementation on stress response in pregnant women living in inner-city poverty, and the first study of maternal DHA supplementation on emotion and stress regulation in their infants. Relevance: If DHA supplementation is associated with reductions in perceived stress, more modulated maternal cortisol response to stress, and more optimal emotional and behavioral regulation in the infant, even within the context inner-city poverty, then a comprehensive program of research on the mechanisms by which these associations evolve and the potential for broad-based prevention of poor developmental outcomes among children born to women living in poverty can be launched. PUBLIC HEALTH RELEVANCE: This will be the first study of the effect of essential fatty acid supplementation in pregnant women living in inner-city poverty on the stress response system during pregnancy. If essential fatty acid supplementation is associated with reductions in the experience of stress, more modulated hormonal response to stress, and more optimal regulation of emotion and attention in the infant, even within the context inner-city poverty, then a comprehensive program of research on the role of nutrition on stress during pregnancy can be launched. This study may be the first step toward broad-based prevention of poor developmental outcomes among children born to women living in poverty.
描述(申请人提供):生活在贫困中的孕妇经常经历长期的压力,因此压力荷尔蒙水平较高。在子宫内暴露于高水平的应激激素会对发育中的胎儿产生负面影响,随后会对婴儿的情绪和行为调节能力产生负面影响。在这项提案中,我们描述了一项正在开发的研究计划,旨在通过在怀孕期间补充二十二碳六烯酸(DHA)来减少产前应激对婴儿健康和发育的负面影响。DHA是omega-3脂肪酸家族中的一种长链多不饱和脂肪酸。DHA在神经细胞膜中的浓度最高,影响受体功能、神经递质摄取和信号传递。越来越多的证据表明,饮食中低水平的DHA摄入量与对压力的次优反应有关,补充DHA可以调节压力反应。目的:这项拟议研究的目标是探索怀孕期间补充DHA是否与以下因素有关:1)减少孕妇在怀孕期间感受到的压力;2)孕妇在怀孕期间对压力刺激做出更有规律的皮质醇反应;以及3)对婴儿的情绪和行为进行更优化的调节。方法:65名居住在市中心贫困地区的孕妇,每周食用不到两份鱼,将被随机分配到从怀孕16-20周开始每天服用450毫克DHA或安慰剂,直到怀孕结束。将在基线、怀孕24周、30周、36周以及产后4个月评估感知压力、妊娠相关压力、应激性生活事件、焦虑和抑郁。DHA水平将在基线和怀孕36周时进行评估。皮质醇对Trier社会压力测试的反应将在基线、24周和30周进行测量。在产后4个月,婴儿的气质、认知发展和应激反应将在实验室进行评估。研究人员:这一建议源于NIMHR21翻译科学网络关于产前压力和后代心理健康结果的研究。该网络的三名成员基南、卡特和格洛弗博士都是产前应激和儿童心理健康领域的研究人员,这是可能直接影响临床护理的优先探索性研究领域。他们正在就本应用程序进行合作。创新:这将是第一项关于补充DHA对生活在市中心贫困地区的孕妇压力反应影响的随机对照研究,也将是第一项关于孕妇补充DHA对婴儿情绪和压力调节的研究。相关性:如果补充DHA与感知压力的减少、母亲对压力的更有调节的皮质醇反应以及婴儿更理想的情绪和行为调节有关,即使在市中心贫困的背景下也是如此,那么就可以启动一项全面的研究计划,研究这些联系的演变机制,以及广泛预防贫困妇女所生儿童发育不良结果的可能性。公共卫生相关性:这将是对生活在市中心贫困地区的孕妇补充必需脂肪酸对怀孕期间压力反应系统影响的第一项研究。如果补充必需脂肪酸与减少压力体验、更多调节荷尔蒙对压力的反应以及对婴儿情绪和注意力的更优化调节有关,即使在市中心贫困的背景下,也可以启动一项关于营养对怀孕期间压力的作用的综合研究计划。这项研究可能是向广泛预防贫困妇女所生儿童的不良发展结果迈出的第一步。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathryn Elizabeth Keenan其他文献

Kathryn Elizabeth Keenan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathryn Elizabeth Keenan', 18)}}的其他基金

A Developmental Approach to Testing Suicidal Phenotypes in Early Childhood in Black Youth
测试黑人青少年童年早期自杀表型的发展方法
  • 批准号:
    10728686
  • 财政年份:
    2023
  • 资助金额:
    $ 19万
  • 项目类别:
Examining biomarkers and mechanisms of health disparities in sexual minority women
检查性少数女性健康差异的生物标志物和机制
  • 批准号:
    9442855
  • 财政年份:
    2017
  • 资助金额:
    $ 19万
  • 项目类别:
Examining biomarkers and mechanisms of health disparities in sexual minority women
检查性少数女性健康差异的生物标志物和机制
  • 批准号:
    9291370
  • 财政年份:
    2017
  • 资助金额:
    $ 19万
  • 项目类别:
Examining biomarkers and mechanisms of health disparities in sexual minority women
检查性少数女性健康差异的生物标志物和机制
  • 批准号:
    9922364
  • 财政年份:
    2017
  • 资助金额:
    $ 19万
  • 项目类别:
Individual differences in estrogen during late adolescence: Impact on functioning of positive and negative valence systems - Resubmission 01
青春期后期雌激素的个体差异:对正价和负价系统功能的影响 - 重新提交 01
  • 批准号:
    9534189
  • 财政年份:
    2017
  • 资助金额:
    $ 19万
  • 项目类别:
Improving maternal and child health through prenatal fatty acid supplementation: A randomized controlled study in African American women living in low-income urban environments
通过产前补充脂肪酸改善孕产妇和儿童健康:一项针对生活在低收入城市环境中的非裔美国妇女的随机对照研究
  • 批准号:
    8942030
  • 财政年份:
    2015
  • 资助金额:
    $ 19万
  • 项目类别:
Improving maternal and child health through prenatal fatty acid supplementation: A randomized controlled study in African American women living in low-income urban environments
通过产前补充脂肪酸改善孕产妇和儿童健康:一项针对生活在低收入城市环境中的非裔美国妇女的随机对照研究
  • 批准号:
    9135142
  • 财政年份:
    2015
  • 资助金额:
    $ 19万
  • 项目类别:
ISRCAP Biennial Meeting
ISRCAP 双年度会议
  • 批准号:
    8130085
  • 财政年份:
    2011
  • 资助金额:
    $ 19万
  • 项目类别:
Developmental comorbidity of pain and depression in preadolescent girls
青春期前女孩疼痛和抑郁的发育合并症
  • 批准号:
    7658508
  • 财政年份:
    2009
  • 资助金额:
    $ 19万
  • 项目类别:
Developmental comorbidity of pain and depression in preadolescent girls
青春期前女孩疼痛和抑郁的发育合并症
  • 批准号:
    7816818
  • 财政年份:
    2009
  • 资助金额:
    $ 19万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 19万
  • 项目类别:
    Collaborative R&D
Application name Phase Space - VR hypnotherapy as early intervention for anxiety in students and young people
应用程序名称 Phase Space - VR 催眠疗法作为学生和年轻人焦虑的早期干预
  • 批准号:
    10055011
  • 财政年份:
    2023
  • 资助金额:
    $ 19万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了